December 27, 2014 7:01 PM ET

Pharmaceuticals

Company Overview of Intellikine, Inc.

Company Overview

Intellikine, Inc. discovers and develops small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation, and autoimmune disorders. The company products include INK128, an orally-available TORC1/2 inhibitor for the treatment of solid tumor malignancies; INK1197, a small molecule dual PI3K selective inhibitor for patients with immune-mediated inflammatory diseases, such as rheumatoid arthritis and asthma; and PI3K selective inhibitors for the treatment of hematologic malignancies and solid tumors. The company was founded in 2007 and is based in La Jolla, California. As of January 2012, Intellikine, Inc. operates as a subsidiary of Takeda America Holding...

10931 North Torrey Pines Road

Suite 103

La Jolla, CA 92037-1044

United States

Founded in 2007

Phone:

858-768-6500

Fax:

858-558-5988

Key Executives for Intellikine, Inc.

Co-Founder
Vice President
Director
Age: 53
Board Observer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Health Plus International, Inc. United States
Nerveda, Inc. United States
Aquarius Cannabis Inc. United States
TrueYou.com, Inc. United States
Catalyst Pharmaceutical Research, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intellikine, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.